Physician profile
Jeffrey Brabham
NPI 1639336233
$720.05
in general payments reported to CMS, 2019-2025
14 companies · $251 in 2025
The $251 reported for 2025 was more than what a typical Radiation Oncology provider received nationally (typical 2025 total: $172).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $162 · 2020: $13.67 · 2021: $18.07 · 2022: $59.78 · 2023: $175 · 2024: $40.79 · 2025: $251.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $466.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $466.15 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Elekta, INC. | $200.52 | 2020-2025 | Mosaiq |
| Glaxosmithkline, LLC. | $124.89 | 2023 | Jemperli |
| Boston Scientific Corporation | $114.50 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $52.06 | 2022-2025 | Imfinzi |
| 180 Medical, INC. | $33.56 | 2019 | |
| Teleflex LLC | $32.74 | 2025 | Barrigel |
| Kyowa Kirin, INC. | $30.28 | 2021-2022 | |
| Blue Earth Diagnostics | $24.58 | 2024 | |
| Smith+Nephew, INC. | $23.92 | 2022 | |
| Regeneron Healthcare Solutions, INC. | $21.88 | 2025 | Libtayo |
| Evoke Pharma, INC. | $16.68 | 2025 | |
| Bioprotect Medical, INC. | $16.21 | 2024 | Bioprotect Balloon Implant System |
| Sun Pharmaceutical Industries INC. | $14.32 | 2019 | |
| Helsinn Therapeutics (U.S.), INC. | $13.91 | 2023 | Valchlor |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jeffrey Brabham listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.